Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | CFTR | P13569 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NPY2R | P49146 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL15313341 | 0.97 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1MEN1KMT2ACA2 | |
| Iodide SCHEMBL15313340 | 0.95 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MEN1KMT2ACA2 | |
| SCHEMBL28890291 | 0.83 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MEN1KMT2ACA2 | |
| SCHEMBL28492227 | 0.80 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1MEN1KMT2ACA2 | |
| SCHEMBL10608636 | 0.79 | L3MBTL1 (0.56) | ALDH1A1L3MBTL1MEN1KMT2ACA2 | |
| SCHEMBL29086939 | 0.79 | CA2 (0.52) | ALDH1A1L3MBTL1MEN1KMT2ACA2 | |
| SCHEMBL7277887 | 0.78 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1MEN1KMT2ACA2 | |
| SCHEMBL5877657 | 0.78 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1MEN1KMT2ACA2 | |
| SCHEMBL27494600 | 0.76 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MEN1KMT2ACA2 | |
| SCHEMBL18951487 | 0.75 | L3MBTL1 (0.48) | ALDH1A1L3MBTL1MEN1KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1067 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025073057-A1 | METHODS FOR PREPARING SULFILIMINES AND SULFOXIMINES FROM THIOETHERS USING O-(DIPHENYLPHOSPHINYL)HYDROXYL AMINE (DPPH), AND AMATOXIN ANALOGS PREPARED FROM SUCH METHODS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-04-10 | — | — | WO | claimed |
| CN-117069063-A | Sodium hydride suspension and application thereof in flow chemical reaction | 武汉药明康德新药开发有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-112552339-A | Preparation method of O-diphenylphosphoryl hydroxylamine | 安徽昊帆生物有限公司 | 2021-03-26 | — | — | CN | claimed |
| US-20060264624-A1 | Methods for synthesizing imidazotriazinones | LEXICON GENETICS INCORPORATED | 2006-11-23 | — | — | US | claimed |
| WO-2026104680-A1 | NOVEL SULFONAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026104681-A1 | NEW SULFONAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026104678-A1 | NOVEL SULFONAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2026-05-21 | — | — | WO | disclosed |
| EP-4745134-A1 | PROTEIN ARGINASE METHYLTRANSFERASE-5 INHIBITOR AND MEDICAL USE THEREOF | Jiangsu Yahong Meditech Co., Ltd. (CN) | 2026-05-20 | — | — | EP | disclosed |
| US-20260132136-A1 | Pyrazolo[5,1-f][1,2,4]triazin-4-ones as inhibitors of NOX4 | BOEHRINGER INGELHEIM INT GMBH (DE) | 2026-05-14 | — | — | US | disclosed |
| EP-4211119-B1 | 2-AMINOQUINAZOLINES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MERCK SHARP & DOHME LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739690-A1 | SUBSTITUTED QUINOLYL/QUINOXALYL DIHYDROPYRROLOTRIAZINE COMPOUNDS FOR COMBATTING PHYTO-PATHOGENIC FUNGI | BASF SE (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739691-A1 | SUBSTITUTED PYRIDYL/PYRAZINYL DIHYDROPYRROLOTRIAZINE COMPOUNDS FOR COMBATTING PHYTOPATH-OGENIC FUNGI | BASF SE (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-0292191-A1 | 2-(Substituted methyl)-1-alkylcarbapenem derivatives | MERCK & CO. INC. (US) | 1988-11-23 | — | — | EP | disclosed |
| EP-0266532-A1 | 1,3-Disubstituted imidazolium salts | F. HOFFMANN-LA ROCHE AG (CH) | 1988-05-11 | — | — | EP | disclosed |
| EP-0253084-A2 | 1,3-Disubstituted imidazolium salts | F. HOFFMANN-LA ROCHE AG (CH) | 1988-01-20 | — | — | EP | disclosed |
| EP-0200947-A1 | 1,3-Disubstituted imidazolium salts | F. HOFFMANN-LA ROCHE AG (CH) | 1986-11-12 | — | — | EP | disclosed |
| EP-0181926-A1 | SUBSTITUTED CUBANES | UNIVERSITY PATENTS, INC. (US) | 1986-05-28 | — | — | EP | disclosed |
| WO-1985005357-A1 | SUBSTITUTED CUBANES | UNIVERSITY PATENTS, INC. (US) | 1985-12-05 | — | — | WO | disclosed |
| US-4539148-A | OXYGENATED BUTYRIC ACID DERIVATIVES OF OXOAZETIDINE | SHIONOGI & CO., LTD. (JP) | 1985-09-03 | — | — | US | disclosed |
| EP-0102893-A1 | A novel production of 1-oxacephams | SHIONOGI & CO., LTD. (JP) | 1984-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132136-A1 | Pyrazolo[5,1-f][1,2,4]triazin-4-ones as inhibitors of NOX4 | NOX4, NOX1, NOX3 | ALDH1A1 161/4885L3MBTL1 3608/4885MEN1 4824/4885 |
| US-20060264624-A1 | Methods for synthesizing imidazotriazinones | PDE3A, PDE2A, PDE3B | ALDH1A1 1422/4885L3MBTL1 4829/4885MEN1 2618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.